News

Sigmoidoscopy is best for bowel screens

08-Dec-06

Flexible sigmoidoscopy is the most cost-effective bowel cancer screening strategy and should be included in the national bowel cancer-screening programme, say UK researchers.

Current bowel screening pilot schemes that target individuals aged 58–69 years use faecal occult blood testing in conjunction with further investigation by colonoscopy.  

Researchers produced a colorectal cancer-screening model to inform the DoH’s policy on bowel cancer screening.  

They looked at the costs, effects and resource impact of five different screening options.  

They found screening using flexible sigmoidoscopy, with or without faecal occult blood testing, might be more cost-effective  and produce benefits compared with a policy of no screening.  

However, the researchers warn that the introduction of any screening option would require significant investment.

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

Golden rules for registrars

Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more

Career paths - Working abroad in a rural practice

Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more

Professional development - Honing your presentation skills

Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more

Show all articles

 

Latest Clinical Articles

Clinical Review - Malaria

Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Show all clinical articles

MIMS Product News

New drug - Xamiol

Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more

New drug - Xarelto

Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more

New drug - Torisel

Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more

Jobs

 

Job of the Week